Results 161 to 170 of about 30,642,264 (240)

The efficacy and tolerability of latency-reversing agents in reactivating the HIV-1 reservoir in clinical studies: a systematic review. [PDF]

open access: yesJ Virus Erad, 2023
Debrabander Q   +7 more
europepmc   +1 more source

PEBP1 Regulates Ferroptosis in Acute Glaucoma: Targeted Therapy Using Engineered Exosomes

open access: yesThe FASEB Journal, Volume 40, Issue 17, 15 September 2026.
General schematic diagram of Spatial and Single‐Cell Transcriptomics Identifies PEBP1 as a Ferroptosis Mediator in Glaucoma: Targeted Intervention by Engineered Stem Cell Exosomes. ABSTRACT Glaucoma is the leading cause of irreversible blindness worldwide, primarily driven by the progressive loss of retinal ganglion cells (RGCs) under pathological high
Yijia Huang   +13 more
wiley   +1 more source

Effect of high dose vitamin D<sub>3</sub> on the HIV-1 reservoir: A pilot randomised controlled trial. [PDF]

open access: yesJ Virus Erad, 2023
Pitman MC   +13 more
europepmc   +1 more source

Innate immune imprints shape HIV-1 reservoir cell persistence during long-term antiretroviral therapy. [PDF]

open access: yesNat Immunol
Tan TS   +24 more
europepmc   +1 more source

Targeted plasma proteomics identifies MICA and IL1R1 proteins associated with HIV-1 reservoir size. [PDF]

open access: yesiScience, 2023
Blaauw MJT   +13 more
europepmc   +1 more source

HIV-1 reservoir evolution in infants infected with clade C from Mozambique. [PDF]

open access: yesInt J Infect Dis, 2023
Koofhethile CK   +16 more
europepmc   +1 more source

Changes in HIV-1 Reservoir Dynamics After Mpox Infection. [PDF]

open access: yesJ Med Virol
Casado-Fernández G   +14 more
europepmc   +1 more source

TCR-mimic bispecific antibodies to target the HIV-1 reservoir. [PDF]

open access: yesProc Natl Acad Sci U S A, 2022
Sengupta S   +24 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy